ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
2,64
0,13
(5,18%)
Fermé 24 Décembre 10:00PM
2,64
0,00
( 0,00% )
Avant marché: 1:03PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
2,64
Prix Achat
2,58
Prix Vente
2,70
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,50 Plage de 52 semaines 4,95
Cap du marché
Clôture Veille
2,64
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
107 117
Actions en circulation
112 824 183
Rendement du Dividende
-
Ratio Cours sur Bénéfices
7,00
Bénéfice par action (BPA)
0,38
Chiffre d'affairess
409,92M
Bénéfice net
42,54M

À propos de Procaps Group SA

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardio... Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. Show more

Secteur
Medicinal Chems,botanicl Pds
Industrie
Medicinal Chems,botanicl Pds
Siège social
Luxembourg City, Luxembourg, Lux
Fondé
-
Procaps Group SA est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker PROC. Le dernier cours de clôture d'Procaps était de US$2,64. Au cours de la dernière année, les actions de Procaps ont été négociées dans une fourchette de prix de US$ 0,50 à US$ 4,95.

Procaps compte actuellement 112 824 183 actions en circulation. La capitalisation boursière d'Procaps est de US$297,86 million. Procaps a un ratio cours/bénéfice (ratio PE) de 7.00.

PROC Dernières nouvelles

Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates

MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Group Announces Financing, Shareholders Agreement and Board Updates

MIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company...

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Issues Shareholder Letter

MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Group Announces New Chairman

Ruben Minski decides to step down as Executive Chairman and José Minski is appointed as new Chairman of the Board Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Procaps Group (Nasdaq: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has received a letter from the Nasdaq...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.63-19.26605504593.273.7752.4747932.90519944CS
41.46123.7288135591.183.7751.16141028592.23935356CS
120.4319.45701357472.213.7750.51071171.47290977CS
26-0.06-2.222222222222.73.7750.5530731.50645779CS
52-0.82-23.69942196533.464.950.5345721.9530273CS
156-6.6-71.42857142869.2410.20.5276114.28247672CS
260-5.77-68.60879904888.4111.980.5327025.48236178CS

PROC - Frequently Asked Questions (FAQ)

What is the current Procaps share price?
The current share price of Procaps is US$ 2,64
How many Procaps shares are in issue?
Procaps has 112 824 183 shares in issue
What is the market cap of Procaps?
The market capitalisation of Procaps is USD 297,86M
What is the 1 year trading range for Procaps share price?
Procaps has traded in the range of US$ 0,50 to US$ 4,95 during the past year
What is the PE ratio of Procaps?
The price to earnings ratio of Procaps is 7
What is the cash to sales ratio of Procaps?
The cash to sales ratio of Procaps is 0,73
What is the reporting currency for Procaps?
Procaps reports financial results in USD
What is the latest annual turnover for Procaps?
The latest annual turnover of Procaps is USD 409,92M
What is the latest annual profit for Procaps?
The latest annual profit of Procaps is USD 42,54M
What is the registered address of Procaps?
The registered address for Procaps is 9, RUE DE BITBOURG, LUXEMBOURG CITY, LUXEMBOURG, L-1273
What is the Procaps website address?
The website address for Procaps is www.procapsgroup.com
Which industry sector does Procaps operate in?
Procaps operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AVGRAvinger Inc
US$ 1,81
(181,76%)
49,23M
CREVCarbon Revolution Public Ltd
US$ 9,42
(142,16%)
3,91M
BAOSBaosheng Media Group Holdings Ltd
US$ 3,59
(107,51%)
11,97M
CMNDClearmind Medicine Inc
US$ 2,53
(107,38%)
31,17M
TIVCTivic Health Systems Inc
US$ 0,398
(77,36%)
42,03M
SLGLSol Gel Technologies Ltd
US$ 0,938
(-43,15%)
766,66k
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15,32
(-31,05%)
2,28k
AGFYAgrify Corporation
US$ 26,525
(-25,89%)
16
GLDDGreat Lakes Dredge and Dock Corporation
US$ 9,01
(-21,96%)
2
KALVKalVista Pharmaceuticals Inc
US$ 7,00
(-20,72%)
184
SVMHSRIVARU Holding Ltd
US$ 0,0344
(22,86%)
161,29M
AVGRAvinger Inc
US$ 1,81
(181,76%)
49,23M
TIVCTivic Health Systems Inc
US$ 0,398
(77,36%)
42,03M
WBUYWeBuy Global Ltd
US$ 0,21
(24,93%)
31,67M
CMNDClearmind Medicine Inc
US$ 2,53
(107,38%)
31,17M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock